Evidence map›Paper›PMID 42458627›Full record

ArticleThe American journal on addictions2026

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series.

John McMaster, Saumiya Seshakumaran, Hesitha Abeysundera, Isha Tipirneni, Rita Hormiz

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The American journal on addictions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John McMasterAlcohol and Other Drugs Service, Gold Coast Health, Gold Coast, Queensland, Australia.ORCID https://orcid.org/0009-0003-5577-4468
Saumiya SeshakumaranAlcohol and Other Drugs Service, Gold Coast Health, Gold Coast, Queensland, Australia.ORCID https://orcid.org/0009-0004-6821-3878
Hesitha AbeysunderaAlcohol and Other Drugs Service, Gold Coast Health, Gold Coast, Queensland, Australia.ORCID https://orcid.org/0000-0001-7633-7601
Isha TipirneniBond University, Gold Coast, Queensland, Australia.ORCID https://orcid.org/0009-0005-6624-3210
Rita HormizBond University, Gold Coast, Queensland, Australia.ORCID https://orcid.org/0009-0007-6922-6672

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesPoppy seed tea (PST) contains unpredictable opioid concentrations, destabilising tolerance and increasing overdose risk. Extended-release buprenorphine (BUP-XR) provides sustained coverage without daily dosing.

methodsEighteen-month follow-up of adults (N = 3) with opioid use disorder (OUD) involving PST in Australia.

resultsAll had polysubstance use and transitioned to BUP-XR after 2 days to 6 months of sublingual buprenorphine. Posttransition urine drug screens were morphine-negative; one patient was intermittently tramadol-positive. All remained in treatment at 18 months. DISCUSSION AND

conclusionsBUP-XR assisted stability within multidisciplinary care. SCIENTIFIC SIGNIFICANCE: This series adds longer-term follow-up on PST-related OUD and suggests BUP-XR feasibility.

Indexed as

BuprenorphineNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPapaverAdultDelayed-Action PreparationsFemaleFollow-Up StudiesHumansRetrospective StudiesSeedsBuprenorphineDelayed-Action PreparationsNarcotic Antagonists

Identifiers

PMID42458627
PMCPMC13485313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.